22 May 2024
$9.9m investment in a US methane vaccine startup, ArkeaBio (previously noted on Q2 FY24 Scorecard as undisclosed while the funding round was ongoing)
S5m investment in BioLumic, a NZ biotech company utilising UV light to develop new pasture to reduce emissions and boost productivity.
$1m investment to establish a new vaccine venture to accelerate the New Zealand research and attract external funders.
$29.2m has now been allocated across 10 investments.
We have 77 other potential investment opportunities on our radar – and we continue to scan the globe for solutions that will work for our pastoral farming system.
This Scorecard summarises progress as at 31 March 2024 (end of Q3 FY24).
